Loading
Latest filing published 10 Jan 2019 for MediPharm Labs Corp. (formerly POCML 4 Inc.), €49k.
No signal scores available.
Christopher Hobbs discloses dealings in MediPharm Labs Corp. (formerly POCML 4 Inc.) to SEDI. Over a trading history stretching from 1 October 2018 to 7 January 2019, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 10 January 2019, reports an option exercise of €49k in MediPharm Labs Corp. (formerly POCML 4 Inc.). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations